Table 1 The correlations between CBX7 expression and clinicopathologic variables, and p16 expression
From: Oncogenic role of the chromobox protein CBX7 in gastric cancer
Variables | CBX7 n (%) | Â | |
|---|---|---|---|
| Â | (-) | (+) | P value* |
Gender | Â | Â | Â |
   Male | 34(68.0) | 16(32.0) |  |
   Female | 16(64.0) | 9(36.0) | 0.729 |
Age (years) | Â | Â | Â |
   <60 | 15(50.0) | 15(50.0) |  |
   ≥60 | 35(77.8) | 10(22.2) | 0.012 |
Size(cm) | Â | Â | Â |
   <4.5 | 26(65.0) | 14(35.0) |  |
   ≥4.5 | 24(68.6) | 11(31.4) | 0.743 |
Histology | Â | Â | Â |
   Well differentiated | 22(71.0) | 9(29.0) |  |
   Poorly differentiated | 28(63.6) | 16(36.4) | 0.507 |
T classification | Â | Â | Â |
   T1/2 | 19(76) | 6(24) |  |
   T3/4 | 31(62.0) | 19(38.0) | 0.605 |
LNM | Â | Â | Â |
   Negative | 31(77.5) | 9(22.5) |  |
   Positive | 19(54.29) | 16(45.71) | 0.035 |
Distant metastasis | Â | Â | Â |
   Negative | 48(82.76) | 21(17.24) |  |
   Positive | 2(56.52) | 4(43.48) | 0.071 |
Clinical stage | Â | Â | Â |
   I/II | 24(84.6) | 5(15.4) |  |
   III/IV | 26(60.0) | 20(40.0) | 0.02 |
p16 | Â | Â | Â |
   Negative | 18(58.1) | 13(41.9) |  |
   Positive | 32(72.7) | 12(27.3) | 0.188 |